individuals. After repeated encounters, most young adults generally harbor cross-reactive, 46 long-lived humoral and T-cell responses [1] [2] [3] that are thought to work together to efficiently blunt subsequent HAdV-induced morbidity. However, in spite of the robust anti-114 CD4 + T cells harbored a conventional memory phenotype (CD45RO + /FoxP3 -/CD25 -115 /CD127 + ) ( Figure 1C) . These data demonstrate the presence of HAdV-specific T regs in 116 healthy adults.
117
To determine if putative HAdV-specific T regs have regulatory functions, we incubated 118 CFSE-labeled PBMCs, or PBMCs depleted in CD25-expressing cells, with a hexon 119 peptide pool and quantified T-cell proliferation. We found that depletion of all CD25 + cells 120 caused CD4 + cells to proliferate greater than control peptide-challenged CD4 + cells 121 ( Figure 1D ), suggesting that the HAdV-specific T regs in the CD25 + population can restrict 122 the proliferative anti-HAdV-specific T cells. Taken together, these data indicate that a 123 fraction of HAdV-specific CD4 + T cells harbors an inducible T reg phenotype, and that 124 healthy adults have T regs that dampen the proliferation of HAdV-specific T cells. [13, 14] . As these profiles are also inconsistent with that of tolerogenic DCs, we 149 hypothesized that it was not due to IC-activated DCs, but rather an effect on bystander 150 DCs.
126

151
To assess the impact of IC-HAdV5-induced pyroptosis and DC maturation on bystander 152 DCs we developed a transwell assay (Figure S1A for schematic). Briefly, CD14 + 153 monocytes isolated from fresh buffy coats were induced to differentiate into immature DCs 154 for 6 days. Immature DCs seeded in 12-well plates were mock-treated, challenged with 155 bacterial lipopolysaccharides (LPS), HAdV5, IgGs, or IC-HAdV5 (these cells will be 156 referred to "direct DCs"). At 6 h post-challenge, a transwell insert was added and naive 157 immature DCs (bystander DCs) from the same donor were seeded in the upper chamber 158 (see Figure S1B -D for controls concerning transfer of HAdV5 particles between chambers 159 and cell death). Twelve hours after adding the bystander DCs to the upper chamber, the 160 direct and bystander DCs were collected and assayed as described below. Compared to 161 bystander DCs stimulated by direct DCs challenged with IgG or HAdV5, bystander DCs 162 stimulated by IC-HAdV5-challenged DCs increased their cell surface levels of the 163 maturation/activation markers CD80, CD83, CD86 (Figure 2A) , CD40, and MHC II 164 ( Figure S2A) . The level of CD86 on bystander DCs tended to increase as the number of 165 IC-HAdV5 particles increased during the stimulation of the direct DCs (Figure S2B) . The 166 cell surface increase of CD86 and CD83 was also accompanied by an increase in total 167 (cell surface + intracellular) CD86 and CD83 levels (Figure 2B) . Together, these data 168 demonstrate that IC-HAdV5-challenged DCs enhanced the synthesis and cell surface 169 expression of maturation/activation markers on bystander DCs. array. Three principal components showed 61% (F1), 28% (F2), and 11% (F3) accordance. C) TNF, IFNβ, 226 and CXCL10 mRNA levels in bystander DCs. Direct DCs were mock-, IgG-, LPS-, HAdV5-, or IC-HAdV-227 challenged. IC-HAdV5s were used at 20 x 10 3 , 10 x 10 3 , 5 x 10 3 , or 1 x 10 3 physical particles/direct DC.
228
Assays were carried out in 3 donors in at least duplicates. The fold increase is shown as mean ± SEM. See 229 Figure 3C) and IL1β, IL12 (p40), CCL3 and IL6 (Figure S2D) we compared mRNA levels of TNF, IFNβ (Figure 3D) , Mip-1α and IL6 (Figure S3 , which 245 also includes dose-dependent response). Globally, mRNAs that code for pro-inflammatory 246 molecules were 2 to 10-fold greater in direct DCs than in bystander DCs. In addition, only 12 h post-challenge, rinsed, and then placed in a separate well with fresh medium for 9 h 255 before collecting the medium. The direct DC medium was collected at 12 h post-256 challenge, or after a wash at 12 h and then collected 9 h later (21 h) to compare 257 conditions similar to that used for bystander DCs (see Figure 4A for schematic). 
262
These data are consistent with previous results showing the robust maturation of IC-
263
HAdV5-challenged DCs [13, 14] . HAdV5-challenge DCs that were rinsed 12 h post-264 stimulation had overall lower cytokine levels than prior to washing, but TNFSF10, CXCL9, 265 CXCL11, and CCL5 levels remained robust (Figure 4C , middle columns). Interestingly, 266 instead of a positive correlation between the cytokine secretion and the IC-HAdV5 dose, 267 we found that as the IC-HAdV5 dose increased, the cytokines secreted by direct DCs 268 tended to decrease (Figure 4C , middle columns).
269
Using HAdV5-challenged DCs (without IgGs) to generate bystander DCs, we found that 270 the latter secreted 3 to 12-fold higher levels of TNFSF10, CCL5, CXCL9, CXCL10 and 271 CXCL11 compared to bystander DCs exposed to the medium from IgG-challenged DCs 272 (Figure 4D , second column). Similarly, when bystander DCs were generated using IC-
273
HAdV5-challenged DCs, the level of the above five cytokines also increased. In addition, three chemokines involved in immune cell recruitment (CCL15, CCL20, and CCL2) 275 increased >3 fold. Consistent with the transcriptome analyses, we did not find a notable 
325
Cytokines and pyroptosis-associated factors impact bystander DC phenotype combination of drugs and mutant viruses to selectively modify the environment created by 328 IC-HAdV5-challenged DCs. To determine the impact of IL-1, direct DCs were pre-treated 329 with ZVAD, a pan-caspase inhibitor that blocks caspase 1 auto-cleavage and pro-IL-1 330 processing. Importantly, ZVAD has no effect on TNF and canonical protein secretion 331 ( Figure S4A and reference [14] ). We found that blocking IL-1 production by direct DCs 332 reduced bystander DC maturation as demonstrated by their lower levels of CD86 and 333 CD83 (Figure 5A-B) . We then used brefeldin A to block ER to Golgi-mediated cytokine 334 secretion in direct DCs (see Figure S4B for controls). Of note IL-1β release is not 335 significantly affected by brefeldin A, (Figure S4C) . In brefeldin A-treated IC-HAdV5-336 challenged DCs the levels of CD83 and CD86 did not change markedly (Figure 5C) , while 337 the bystander DCs responded with lower levels of CD83 and CD86 ( Figure 5D ).
338
Next, we generated ICs using Ad L40Q [31] , an HAdV5 capsid containing a mutated protein 339 VI that attenuates endosomolysis. While IC-Ad L40Q poorly induces pyroptosis in direct DCs
340
[14], they secrete levels of TNF that are similar to IC-HAdV5-challenged DCs.
341
Furthermore, IFNβ and IL1β mRNA levels are lower [14] . We found notably lower levels of 342 CD86 and CD83 on bystander DCs following stimulation with the response from IC-
343
HAdV5 versus IC-Ad L40Q -challenged DCs. In addition, the reduced maturation/activation 344 effects were only modestly altered by increasing the IC-Ad L40Q dose (Figure 5E ).
345
Together, these data demonstrate a role for pyroptosis-associated factors in the 346 maturation of bystander DCs.
347
We then compared cytokine mRNA levels in bystander DCs stimulated by HAdV5-, IC-348 Ad L40Q -, or IC-HAdV5-challenged DCs (Figure 5F and Figure S5A -C). Consistent with the 349 phenotype, the transcriptional responses of bystander DCs to both ICs were globally 350 higher than to HAdV5 alone. The bystander DC transcriptional response to IC-Ad L40Q -351 challenged DC milieu was generally lower than in IC-HAdV5-challenged DCs, and it was 352 qualitatively distinguishable as determined by PCA ( Figure 5G ).
353
We then assessed the effect of pyroptosis using IC-Ad2ts1. Ad2ts1 has a hyper-stable 354 capsid due to a mutation in protease that results in failure to process the capsid pre-355 protein [32, 33] . We previously showed that IC-Ad2ts1 poorly induces DC pyroptosis, likely 356 because the HAdV genome does not escape from the capsid and therefore does not (Figure 6A ). CD83 and, to a lesser 390 extent, CD86 levels were also reduced ( Figure 6B) . These data suggest that bystander These data demonstrate that pyroptosis factors other than IL-1β inhibit monocyte chemoattractants ( Figure 5 ). There was also a trend towards greater recruitment when 456 higher IC-HAdV5 doses were used on the direct DCs.
457
Once monocytes migrate into an inflammatory environment they acquire distinct 458 phenotypic and functional profiles [46] . One phenotypic hallmark of monocyte 459 differentiation is CD14, which is high on monocytes and macrophages, but lower on DCs.
460
We therefore characterized migrating and static monocytes for CD14 and CD86 levels at 
519
At day 3, naïve T cells expressed T reg markers in all conditions (except mock-treated 520 direct DCs) (Figure 9B) . At day 7, the number cells with T reg phenotype was near 521 background following incubation in the milieu of mock-, IgG-, or HAdV5-challenged direct 522 DC (Figure 9C) . By contrast, bystander DC created from IC-HAdV-direct DCs had a 523 significant (p < 0.05) increase in cells with a T reg profile. This functional assay 524 demonstrates that bystander DCs can induce naïve CD4 into cells with a T reg phenotype, 525 further supporting our conclusion that they are tolerogenic DCs.
526
As shown in Figure 1D , healthy adults harbor CD25 + cells can inhibit HAdV-specific CD4 + 527 cell proliferation. We therefore asked if the tolerogenic bystander DCs generated in our ex 528 vivo assay could induce the production of HAdV-specific T regs . To address this question 529 we isolated PBMCs, CD14 + monocytes, and naïve CD4 + T cells from 3 donors that 530 harbored anti-HAdV memory T cells (see Figure S10 for flow chart). Briefly, monocytes 531 were used to create direct DCs that were incubated with IC-HAdV-C5. Bystander DCs were generated as previously described. VPD 450-labeled naïve CD4 + T cells were 5,000 cells) were isolated by FACS and mixed with CFSE-labeled PBMCs ± hexon 535 peptides. We found that the ex vivo generated T regs from all donors reduced the 536 proliferation of anti-HAdV T cells (CFSE low /CD4 + ) (Figure 9D) . These data demonstrate 537 that HAdV-specific T regs can be generated via bystander DCs. to whether anti-MAV-1 antibodies are needed to generate T regs to reduce the potential injection of sera from MAV-1-challenged mice into B-cell deficient mice and quantify 591 disease progression. Using nonhuman primates (NHPs) to address the dichotomy 592 between the two arms of the adaptive immune response to adenoviruses is likely a more 593 informative option, but use of NHPs entails unique challenges when it comes to pre-594 existing exposure to their own set of adenoviruses. Nonetheless, Miller and colleagues 595 elegantly showed that NHPs, harboring neutralizing antibody response against a HAdV5 596 host-range mutant, and then re-challenged with the same virus, respond with a significant 597 increase in circulating T regs [53] . These in vivo observations, which hinge on the pre-598 existing neutralizing antibodies, are consistent with our proposed mechanism. One also 599 needs to take into the dynamic, recurrent exposure to HAdVs during childhood and 600 adolescence. These encounters provide multiple opportunities for the formation of IC-
601
HAdVs and the impetus to form HAdV-specific tolerogenic DCs and T regs .
602
Our data also complement the mechanism for HAdV5 persistence described by Hearing . Based on these 620 interactome data, we plotted the possible combinations that could influence the direct and 621 bystander DCs in our assays (Figure S11) . What impact these heterodimers could have 622 on HAdV persistence will require future study, in particular because we did not find 623 notable levels of TGFβ secreted by direct or bystander DCs. More than other cytokine 624 families, the IL-1 family may be primordial because it is tightly linked to IC-HAdV-induced function properties with TLRs. In general, IL-1β release from monocytes is tightly 627 controlled; less than 20% of the total pro-IL-1β precursor is processed and released. IL-1β 628 also increases the expression of intercellular adhesion molecule-1 and vascular cell 629 adhesion molecule−1, which, together with the chemokines, promote the infiltration of 630 cells from the circulation into the extravascular space and then into inflamed tissues [57] . RNase-free water (Qiagen). Reverse transcription was performed with the RT 2 First strand using a RT 2 Profiler TM PCR array (Qiagen). SYBR green PCR conditions were 95°C for 730 10 min and 40 cycles of 95°C for 15 s, and 60°C for 1 min using 84 human inflammatory 731 and receptor genes. The potential mRNAs were chosen and then confirmed by RT-qPCR.
732
The genes that contributed in each axis in the PCA were as follows: F1 = CCL1, 2, 4, 5, 7 733 13, 15, 17, 20, 22, CSF1, CX3CL1, CXCL 1 to 3, 5, 8 to 11, FASLG, IFNG, IL10RA, 734 IL10RB, IL15, IL1a, IL1b, IL7, NAMPT, TNFSF4, 10, 11, 13, 13B, and VEGFA. F2 = 735 AIMP1, C5, CCL1, 2, 13, 17, 23, CRR1, 2, 3, 4, 5, CSF1, CX3CR1, CXCR2, IL10RA, 736 I10RB, IL15, LTA, LTB, MIF, SPP1, TNF, TNFSF4, 10, 11, 13 , and 13B. F3 = CCL17, 23, 737 CCR5, CX3CR1, IL10RA, IL5, IL9, MIF, and OSM. 
749
To assess cell membrane integrity, the cells were collected and centrifuged at a speed of 750 800x g; the cell pellets were then resuspended in PBS, 10% FBS, PI (Sigma), or 7AAD 751 and analyzed on a FacsCalibur flow cytometer (Becton-Dickinson) and FlowJo software.
752
Monocyte migration assay
753
Monocyte migration was evaluated using a 5.0 µm-diameter pore transwell system 754 (Corning, Bagneaux-sur-Loing, France). Monocytes (2 x 10 5 in 200 µl of full media) were 755 added into inserts and DCs or DCs (7.5 x 10 5 in 750 µl of full media) and ± LPS ( IC 1 x 10 4 pp/cell IC 5 x10 3 pp/cell p >0.05
TNF
IC 5 x 10 3 pp/cell IC 1 x 10 3 pp/cell p <0.0001 IC 2 x 10 4 pp/cell IC 1 x 10 4 pp/cell p <0.0001 IC 1 x 10 4 pp/cell IC 5 x 10 3 pp/cell p >0.05
IFNβ
CXCL10
IC 5 x 10 3 pp/cell IC 1 x 10 3 pp/cell p <0.0001 
